Abarelix

Vendor: Abmole

Type: Molecular

SKU: M13376

$132.25 USD
Shipping calculated at checkout.

Documents

Coa

Available in stock (500)

  • Customs clearance fees may apply
  • Worldwide shipping available.
For research use only — not intended for clinical or diagnostic purposes.

Product Overview

Bioactivity
Abarelix (R3827) is the first approved antagonist for the study of GnRH in advanced prostate cancer. Sequence：Ac-{d-2-Nal}-{d-4-Cpa}-{d-3-Pal}-S-{NMyr}-{d-Asp}-L-K(ipr)-P-{d-Ala}-NH2
Casnumber
183552-38-7
Formula
C72H95ClN14O14
Mw
1416.06
Psmiles
CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)N(C)C(=O)C(CO)NC(=O)C(CC3=CN=CC=C3)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C
Purity
>99.0%
Solubility
DMSO : ≥ 14.2 mg/mL
Target synonyms
R3827; PPI 149
Abarelix

Abarelix

$132.25 USD